ON-DEMAND WEBINAR

Deconstructing industry-shifting deals: Pfizer and BioNTech

Mike Ward
Global Head of Thought Leadership, Life Sciences and Healthcare
Clarivate
Sean Marett
Chief Business and Commercial Officer
BioNTech SE

Mike Ward, Clarivate’s Global Head of Thought Leadership, Life Sciences and Healthcare, joined a fireside chat with Sean Marett, Chief Business and Commercial Officer at BioNTech at 2nd annual European HealthTech CEO Forum, to deconstruct the Pfizer-BioNtech deal to develop and distribute Tozinameran, the first COVID-19 vaccine approved worldwide. Mike and Sean discuss pivotal moments in the development of the first-to-finish COVID-19 vaccine:

  • When and how did BioNtech focus on developing a vaccine for COVID-19?
  • What triggered BioNTech to approach Pfizer for partnership?
  • How were they able to develop the vaccine at record speed?
  • What were the challenges they encountered along the way?